Treatment of Vitamin B6 (Pyridoxine) Toxicity
The primary treatment for vitamin B6 toxicity is immediate discontinuation of all vitamin B6 supplementation, followed by symptomatic management of neuropathic pain with medications such as gabapentin, pregabalin, or duloxetine. 1
Diagnosis and Assessment
Confirm vitamin B6 toxicity through:
Be aware that toxicity can occur at various dosages:
Treatment Algorithm
Immediate Discontinuation
- Stop all vitamin B6 supplements 1
- Identify and discontinue any medications or multivitamins containing pyridoxine
Symptomatic Management of Neuropathic Pain
First-line medications 1:
- Gabapentin: Start at 300 mg once daily, gradually increase to 300-600 mg three times daily
- Pregabalin: Start at 75 mg twice daily, gradually increase to 150-300 mg twice daily
- Duloxetine: 60 mg once daily
Second-line medications 1:
- Amitriptyline: 10-25 mg at bedtime, gradually increase to 25-100 mg
- Nortriptyline: 10-25 mg at bedtime, gradually increase to 25-100 mg
For refractory cases:
- Consider low-dose naltrexone 1
Monitoring and Follow-up
Prevention of Recurrence
- If vitamin B6 supplementation is medically necessary (e.g., for isoniazid therapy or other indications):
- Use PLP-based supplements rather than pyridoxine when possible 4
- Consider weekly rather than daily administration (50-100 mg weekly) 4
- Maintain serum PLP levels between 30-60 nmol/L (7.4-15 μg/L) 4
- For patients on isoniazid therapy, use 25-50 mg/day of pyridoxine, increasing to 100 mg/day if peripheral neuropathy develops 2
Important Considerations
- Recovery may be slow and incomplete in some cases, particularly with severe or prolonged toxicity
- Patients with pre-existing neuropathies may be more susceptible to vitamin B6 toxicity
- Educate patients about hidden sources of vitamin B6 in multivitamins and supplements
- The threshold for toxicity varies between individuals, with some developing symptoms at relatively low doses 5, 3
Remember that while vitamin B6 is essential for many biochemical processes, its supplementation should be carefully monitored due to its narrow therapeutic index and potential for neurotoxicity 4.